:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Marc Hilmi, Flore Delecourt, Jérôme Raffenne, Taib Bourega, Nelson Dusetti, Juan Iovanna, Yuna Blum, Magali Richard, Cindy Neuzillet, Anne Couvelard, Matthieu Tihy, Louis de Mestier, Vinciane Rebours, Rémy Nicolle, Jérôme Cros
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	The Journal of Pathology
Online Access:	https://pathsocjournals.onlinelibrary.wiley.com/doi/10.1002/path.6398
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Toward Precision Chemotherapy for Pancreatic Cancer Guided by Transcriptomic Signatures
by: Brice Chanez, et al.
Published: (2025)

Molecular characteristics of early‐onset pancreatic ductal adenocarcinoma
by: Silvana Debernardi, et al.
Published: (2024)

Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues
by: Andrea Vallés‐Martí, et al.
Published: (2024)

Spatial heterogeneity of antibody–drug conjugate targets in pancreatic ductal adenocarcinoma
by: Deema Sabtan, et al.
Published: (2026)

Molecular classification and intratumoral heterogeneity of gastric adenocarcinoma
by: Takeshi Kuwata
Published: (2024)

Differentiating localized autoimmune pancreatitis and pancreatic ductal adenocarcinoma using endoscopic ultrasound images with deep learning
by: Hitomi Nakamura, et al.
Published: (2024)

Identification of serum protein biomarkers for pre‐cancerous lesions associated with pancreatic ductal adenocarcinoma
by: Hannah Mearns, et al.
Published: (2026)

ARP2/3 complex affects myofibroblast differentiation and migration in pancreatic ductal adenocarcinoma
by: Yifeng Sun, et al.
Published: (2024)

Risk factors for suicide in patients with pancreatic ductal adenocarcinoma: A population‐based study
by: Chao Wang, et al.
Published: (2024)

Deciphering transcriptional plasticity in pancreatic ductal adenocarcinoma reveals alterations in sensory neuron innervation
by: Elena Genova, et al.
Published: (2026)

Concurrent targeting of GSK3 and MEK as a therapeutic strategy to treat pancreatic ductal adenocarcinoma
by: Junki Fukuda, et al.
Published: (2024)

Real‐world genome profiling in Japanese patients with pancreatic ductal adenocarcinoma focusing on HRD implications
by: Toshifumi Doi, et al.
Published: (2024)

Association between prediagnostic serum metabolites and pancreatic ductal adenocarcinoma risk in two prospective cohorts
by: Ting Zhang, et al.
Published: (2025)

Novel machine‐learning model for predicting lymph node metastasis in resectable pancreatic ductal adenocarcinoma
by: Susumu Daibo, et al.
Published: (2024)

Peptidase inhibitor 16 promotes proliferation of pancreatic ductal adenocarcinoma cells through OASL signaling
by: Qun Chen, et al.
Published: (2024)

YAP‐LAMB3 axis dictates cellular resistance of pancreatic ductal adenocarcinoma cells to gemcitabine
by: Yecheng Li, et al.
Published: (2024)

Rotational migration in human pancreatic ductal organoids depends on actin and myosin activity
by: Xie, Gengqiang, et al.
Published: (2025)

Stroma gene signature predicts responsiveness to chemotherapy in pancreatic ductal adenocarcinoma patient‐derived xenograft models
by: Alessia Anastasia, et al.
Published: (2025)

The impact of the California state lockdown during the COVID‐19 pandemic on management of patients with pancreatic ductal adenocarcinoma
by: Parisa Oviedo, et al.
Published: (2024)

Plasma cell‐free DNA markers predict occult metastases in patients with resectable pancreatic ductal adenocarcinoma
by: Jacob E. Till, et al.
Published: (2026)

Hexokinase 2 nonmetabolic function‐mediated phosphorylation of IκBα enhances pancreatic ductal adenocarcinoma progression
by: Yingying Tong, et al.
Published: (2024)

Minimally invasive determination of pancreatic ductal adenocarcinoma ( PDAC ) subtype by means of circulating cell‐free RNA
by: Martin Metzenmacher, et al.
Published: (2024)

The inverted U‐shaped relationship between epinephrine and pancreatic ductal adenocarcinoma patients' survival with compensation of lymphocyte
by: Bing‐Xue Li, et al.
Published: (2024)

Evaluation of fine‐needle core biopsy specimens for pancreatic ductal adenocarcinoma: Diagnostic utility and helpful histological features
by: Raul S Gonzalez, et al.
Published: (2024)

Inhibition of PHF1 promotes ferroptosis via IRES‐dependent Snail translation regulation in pancreatic ductal adenocarcinoma
by: Yujiao Xie, et al.
Published: (2026)

Targeting iron–sulfur cluster assembly scaffold protein as a vulnerability in KRAS‐activated pancreatic ductal adenocarcinoma
by: Huarui Cai, et al.
Published: (2024)

Mutant p53 affects the mitochondrial proteome, promoting mitochondrial fragmentation and OXPHOS in pancreatic ductal adenocarcinoma cells
by: Maria Poles, et al.
Published: (2025)

Integration of dual‐energy CT characteristics and biomarkers: Noninvasive prediction of Ki‐67 expression in pancreatic ductal adenocarcinoma
by: Wuyang Zhang, et al.
Published: (2026)

Diagnostic utility of p53, SMAD4, and the novel biomarker PON2 in FNA of pancreatic ductal adenocarcinoma
by: Ruimeng Yang, et al.
Published: (2025)

In Response to Accuracy and Clinical Findings of Saliva Digestive Biomarkers in Laryngopharyngeal Reflux Disease
by: Jerome R. Lechien, et al.
Published: (2026)

A large language model for predicting pancreatic ductal adenocarcinoma patients from blood-derived exosomal transcriptomics data
by: Choudhury, Shubham, et al.
Published: (2026)

Technical recommendation on multiplex MR elastography for tomographic mapping of abdominal stiffness with a focus on the pancreas and pancreatic ductal adenocarcinoma
by: Schattenfroh, Jakob, et al.
Published: (2025)

Nrf2‐mediated adenylosuccinate lyase promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma cells through ferroptosis escape
by: Tung‐Wei Hsu, et al.
Published: (2024)

Response to “The role of adjuvant chemotherapy in management of stage I pancreatic ductal adenocarcinoma deserves independent high quality research”
by: Wooil Kwon, et al.
Published: (2024)

Circulating cell‐free DNA methylation‐based multi‐omics analysis allows early diagnosis of pancreatic ductal adenocarcinoma
by: Guochao Zhao, et al.
Published: (2024)

Single‐cell RNA sequencing and high‐dimensional flow cytometry reveal distinct peripheral immune landscapes of type 1 autoimmune pancreatitis and pancreatic ductal adenocarcinoma
by: Chenxiao Liu, et al.
Published: (2026)

Development of irreversible pancreatic ductal change triggered by pancreatic duct stenting in chronic pancreatitis
by: Kensuke Takuma, et al.
Published: (2024)

Anti‐tumorigenic effects of naive and TLR4‐primed adipose‐derived mesenchymal stem cells on pancreatic ductal adenocarcinoma cells
by: Demet Kaçaroğlu, et al.
Published: (2024)

Serum matrix metalloproteinase‐7, Syndecan‐1, and CA 19‐9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma
by: Doron Yablecovitch, et al.
Published: (2024)

Decoding the Integrated Stress Response of Pancreatic Cancer: Identifying a Serine‐dependent Tumor Subset Under Metabolic Relationships With CAFs.
by: Sauyeun Shin, et al.
Published: (2026)